From a REVOcean.org news release:
REV Ocean will be equipped for conducting missions that cover the entire marine ecosystem. It will be used by scientists and innovators for ‘solutions’ oriented research that explore issues such as the impact CO2 emissions have on the ocean, plastic pollution, and unsustainable fishing. REV Ocean will be an inclusive global vehicle for testing and proliferating ocean solutions. The vessel is 182.9 meters long and will have the capacity of holding 55 scientists and 35 crew. Equipment onboard includes scientific trawls, sonar systems, laboratories, auditorium and classrooms, moonpool, AUV and submarine, an ROV with 6000 meters depth capacity, and advanced communication equipment.
A monumental day for a monumental ship. REV Ocean is thrilled to announce the first water launch of the world’s largest and most advanced research and expedition vessel (REV Ocean). After an extensive and complicated build period over the past 18 months, the vessel was finally lowered into the water today at the VARD Tulcea shipyard in Romania.
Nina Jensen, CEO of REV Ocean, commented: “Today is an especially exciting day, our state-of-the-art research vessel has achieved a major milestone and we are now one step closer to realizing our vision of safeguarding the ocean. We look forward with great anticipation to REV Ocean’s journey to Norway and seeing the next stage of progress towards our ambitions of developing ocean solutions.”
To read more click on the following link: https://www.revocean.org/rev_splash/
…the Getty Villa, despite some anomalies and insertions, is considered a strong likeness, which makes it a powerful locale for “Buried by Vesuvius: Treasures From the Villa dei Papiri,” the first major exhibition of works discovered in the Roman residence. The show includes Weber’s 1758 architectural map—used to build the Getty Villa—along with some of the approximately 90 sculptures pulled from the site, showing athletes, philosophers, rulers, poets and mythological figures. The exhibition also displays findings from the recent excavations.


I built a frame out of ash wood. Then I hand-formed and welded body panels onto the frame. I re-engineered the brakes, the steering and the clutch system to fit properly, and I hand-formed the grille out of aluminum. The seats I built out of plywood, foam and vinyl that looks like leather. When I started, I had no idea how to do any of this.
“While we always believed that high levels of uric acid might be bad for kidneys and that patients with gout may have a higher risk of kidney failure, we were quite surprised by the magnitude of the risk imposed by gout in these patients. We were particularly interested in the risk of advanced kidney disease, as these patients in general have a higher risk of kidney failure and death.
the long and colourful history of haapsalu episcopal castle began when it was built in the 13th century, but since the 17th century the main castle has been in ruins.
It’s a familiar tune to engineer Ken Smith, director of the mobility division of the Stanford Center on Longevity. He says one of the biggest mistakes designers make is to assume that around the age of 60 people lose interest in aesthetics and design. This can have dire consequences for products meant to help people with their health. No one wants to stick a golf-ball-size hearing aid the color of chewed gum in their ear, any more than they want to wear a T-shirt that reads “SENIOR CITIZEN.”
“Asking even seasoned chefs and truffle-industry insiders to describe what the fungus tastes or smells like,” Jacobs writes, “is a bit like asking a priest why he believes in God.” Readers not familiar with the pungent, one-of-a-kind flavor will come away even more intrigued. Those of us whose most frequent encounter with the fabled fungus is through truffle oil will also be disappointed. As Jacobs discovers, nearly all truffle butter and truffle oil sold in America is manufactured using chemicals rather than the real thing.
“Under,” which opened in March, is 
Now, researchers have developed a fast-acting skin patch that efficiently delivers medication to attack melanoma cells. The device, tested in mice and human skin samples, is an advance toward developing a vaccine to treat melanoma and has widespread applications for other vaccines.